TARGETED DISRUPTION OF A CSF1-DAP12 PATHWAY MEMBER GENE FOR THE TREATMENT OF NEUROPATHIC… Application WO-2016057800-A1 World Intellectual Property Organisation (WIPO) 14 Apr 2016